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Abstract 
 
 
 
 
 
 
 
Introduction. It has been shown that S-adenosylmethionine (S-AMe) stimulates 
glutathione synthesis and increases cell resistance to the cytotoxic action of free radicals and 
pro-inflammatory cytokines. The aim of this study was to determine the effect of S-
adenosylmethionine on the oxidative stress in adipose tissue in a model of fructose-induced 
obesity.  
Methods. The study was performed on male Wistar rats divided into 3 groups: control, 
fructose fed (HFD) (35%, 16 weeks), and HFD + S-AMe (20 mg/kg). We examined the 
changes in the ratio of retroperitoneal adipose tissue weight / body weight; levels of reduced 
glutathione (GSH) and malondialdehyde (MDA) in the retroperitoneal adipose tissue, and 
serum levels of GSH and TNF-α.  
Results. Significant increases in the retroperitoneal adipose tissue, MDA, and serum 
TNF-α were identified, as well as decreased tissue and serum levels of GSH in rats fed with 
a high-fructose diet as compared with the control group. In the group fed with HFD and S-
AMe, we found significant reduction in the retroperitoneal adipose tissue and decreased 
levels of MDA and serum TNF-α, as well as increased tissue and serum levels of GSH as 
compared with the group only on HFD.  
In conclusion, our results show that fructose-induced obesity causes oxidative stress in 
hypertrophic visceral adipose tissue. The administration of S-AMe improves the 
antioxidative protection of adipocytes, and reduces oxidative damage and excessive 
accumulation of lipids and inflammation. 
 
 
Acne conglobata is a rare, severe form of acne vulgaris characterized by the presence of comedones, 
papules, pustules, nodules and sometimes hematic or meliceric crusts, located on the face, trunk, neck, arms 
and buttocks.  
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Introduction 
In the last decade, obesity has reached epidemic 
proportions and is considered a major factor in the 
development of metabolic syndrome, type 2 diabetes 
mellitus, non-alcoholic fatty liver disease, cardiovascular 
disease, etc. An important element in the cluster of risk 
factors includes the consumption of ready-made foods 
and beverages with high fructose content, produced by 
the food industry. In humans and in experimental models 
of metabolic syndrome, fructose causes obesity and 
related complications - oxidative stress, hyperglycemia, 
dyslipidemia, hepatic steatosis, and so on (1).  
Obesity is a condition in which a significant increase 
of the adipose tissue in the body occurs due to disturbed 
energy balance, favoring a positive energy balance. The 
increase of adipose tissue in the conditions of over-
nutrition and excess lipids leads to hypoxia and 
increased formation of reactive oxygen species 
(ROS)o(2), which induces low-grade inflammation, 
impaired adipocyte differentiation, chronic remodeling 
of hypertrophic adipose tissue and dysfunction (3). 
These changes are manifested by unregulated secretion 
of adipocytokines with pro-inflammatory, pro-
thrombogenic, hypertensive and diabetogenic effects, 
affecting as well other tissues and organs such as 
endothelium, liver, pancreas, and muscles (4). Some of 
the effects such as TNF-α, IL-6, MCP-1, CRP, etc. also 
induce oxidative stress outside the adipose tissue and 
create conditions for maintaining a systemic pro-
inflammatory state manifested by insulin resistance, 
endothelial dysfunction and tissue injury (5-6). Parallel 
to this, an inhibition in the synthesis of adiponectin is 
observed, which exhibits anti-inflammatory, antidiabetic 
and anti-obesity effects (7-8). Therefore, a number of 
authors have determined oxidative stress and the 
impaired redox balance in the visceral adipose tissue to 
be key factors in the pathogenesis of metabolic 
complications associated with obesity (9). 
In support of this assumption, low levels of GSH 
and antioxidant enzymes such as catalase and 
glutathione peroxidase have been found in the fatty 
tissue of obese people and experimental animals (10), a 
condition prerequisite for increased oxidative stress. 
Regardless of the fact that adipose tissue serves as a 
depot for storage of natural antioxidants (vitamins A, 
vitamin E and carotenoids), in obese humans there are 
low serum levels of these vitamins (11). Based on the 
research literature, it can be concluded that oxidative 
stress in adipose tissue as an adjunct to the early 
metabolic damage in obesity, defines a new approach for 
the treatment and development of therapies. 
In this study, we showed the influence of S-
adenosylmethionine (S-AMe) on oxidative damage in an 
experimental model of metabolic syndrome using rats 
fed with HFD. S-AMe is a methyl group donor and a 
glutathione precursor that is metabolized mainly in the 
liver. S-AMe stimulates GSH synthesis and increases 
cell resistance to the cytotoxic action of free radicals and 
pro-inflammatory cytokines (12). Regarding its 
therapeutic effects, literature data support predominantly 
antioxidative, anti-steatotic, and anti-apoptotic effects in 
various liver diseases. The influence of S-AMe on 
fructose-induced obesity and oxidative stress in visceral 
adipose tissue has not been studied, which defines the 
goal of this investigation. 
 
Materials and Methods  
 
Animal models 
 
Male albino Wistar rats were housed at 20 ± 2ºC 
room temperature under a standard 12 h light/dark cycle. 
All animals received a standard diet and water ad 
libitum. The standard diet was composed of starch- 50%, 
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protein – 20%, fat – 4.5%, 5% cellulose, standard 
vitamins and mineral mix. At the beginning of the 
experiment the body weight of rats was 140 - 180 g. 
After acclimation (two weeks), animals were randomly 
assigned to three groups of seven each: HFD group 
(35% glucose-fructose corn syrup in drinking water for 
16 weeks), HFD+S-AMe group (20 mg/kg b.w. in 
drinking water for 16 weeks), and a control group (water 
drinking). Fructose (Amilym, Bulgaria) and S-AMe 
(NOW Foods, USA) were used. Food intake was 
recorded daily and weights were monitored weekly. At 
the end of the experiment, rats were euthanized with a 
lethal dose of Thiopental. All manipulations were 
performed at 4-8oC. Analysis was performed 
immediately after thawing of the samples. The 
experimental procedures were approved by the Home 
Office for the Care and Use of Laboratory Animals and 
performed with strong consideration for the ethics of 
animal experimentation according to the International 
Guiding Principles for Animal Research approved in 
Bulgaria. 
 
Blood and tissue collection 
At the termination of the experiment, blood was 
collected from the tail vein of rats after pre-narcosis with 
Thiopental at a dose of 15mg / kg i.p. Serum (subject to 
rules of good practice Lab) was used to determine some 
biochemical indicators on the same day, and the 
remainder serum was frozen. Under general anesthesia 
with Thiopental 30mg/kg (rapid intravenous), a 
laparotomy was conducted. We removed various organs 
for research, prepared them as a homogenate, and the 
quickly dissected and froze them. The weight of 
retroperitoneal fat was measured. Tissue extracts were 
prepared by homogenization with buffer PBS-50mM, 
pH=7.4 (1 g tissue, 9ml of buffer) on ice using a Teflon 
glass homogenizer (2000 rpm / 3 min). Homogenates 
were spun in a refrigerated centrifuge (4000 rpm/ 
10min). The supernatant was used for analysis after 
having identified the concentration of protein. 
 
Biochemical Analyses 
 Determination of lipid peroxides. Membrane lipid 
peroxidation was assayed by MDA (malondialdehyde) 
measured by its thiobarbituric acid (TBA) (Merk, 
Germany) reactivity in adipose tissue homogenates using 
the method detailed by Porter et al. (13). Results were 
expressed in nmol MDA per g tissue and were 
determined using the extinction coefficient of MDA–
TBA complex at 532 nm= 1.56 – 10-5 cm-1 M-1 
solution.  
 Determination of total thiols. GSH levels in adipose 
tissue and sera were defined as the total number of 
sulfhydryl groups (SH groups) in the sample. SH groups 
were determined by the method of Hu (14), based on the 
absorption of the color complex between thiol groups 
and 5,5'-dithiobis-(2- nitrobenzoic acid (DTNB) (Merk, 
Germany) at 412 nm. Standard solutions of reduced 
glutathione were used to calculate the concentration of 
thiol groups. 
 Determination of TNF-α levels. Concentrations of 
TNF-α cytokine (IBL International) were measured in 
sera using the commercially available ELISA kit. 
 
Statistical analysis  
An analysis of variance (ANOVA) was used to 
compare the differences in the treatment of experimental 
groups using the .05 significance level. A t-test was used 
to compare the mean values of two groups when 
monitoring the effect of S-AMe on treated and healthy 
rats, with differences between groups significant at p ≤ 
0.05. Statistical analysis of the data was performed by 
using the GraphPad Prism 5.0 software. Graphs were 
drawn with the GraphPad Prism 5.0 graphing program. 
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Results 
Changes in body weight and weight of visceral 
adipose tissue.  
The body weight of the experimental animals was 
measured weekly, with consistent increases in all groups 
through the end of the experiment. Results showed a 
significant progression in obesity in the HFD group 
compared with the control group, with more than 50% 
increase in body weight and a 200% increase in 
retroperitoneal adipose tissue (p <0.0001). In the group 
taking S-AMe, the increase in body weight relative to 
that of the control animals was over 65%, and by more 
than 15% than the HFD group. However, despite the 
increase in final body weight in the S-AMe group, the 
weight of retroperitoneal adipose tissue was statistically 
reduced relative to the HFD group (p < 0.005). 
Therefore, changes in the weight of retroperitoneal 
adipose tissue have been reported as a percentage of the 
total body weight (Figure 1). 
 
Figure 1. Weight of retroperitoneal adipose tissue 
expressed as % of total rat body weight. ***p< 0.05 HFD 
vs. control group;   **p < 0.05 S-AMevs. HFD group 
 
 
Markers of oxidative stress - levels of MDA and SH 
groups.  
The levels of lipid peroxides were identified in a 
homogenate from visceral adipose tissue as amount of 
MDA per gram of protein from the sample. The results 
showed significantly elevated levels of MDA in the HFD 
group (p < 0.0005) relative to the control group. In the 
group fed with S-AMe, lower levels of MDA were found 
compared with the HFD group (p <0.005) and these 
levels were near those of the control group (Figure 2).  
 
Figure 2. Effect of SAMe on HFD – induced changes 
in adipose tissue MDA in rats. .***p < 0.05 HFD vs. 
control group;  **p < 0.05 S-AMevs. HFD group 
GSH levels in adipose tissue and sera were defined 
as the total number of sulfhydryl groups (SH groups) in 
the sample. The results indicate significantly decreased 
levels of SH groups in the retroperitoneal adipose tissue 
in the HFD group (p <0.01) versus the control group. In 
the S-AMe -fed group, the levels of SH groups were 
higher than those in the HFD group (p< 0.05), Figure 
3A. Levels of SH groups in sera showed a significant 
reduction in the HFD group (over 50%) relative to 
controls (p <0.0005), whereas in the S-AMe group, 
levels were significantly higher (p <0.05) as compared 
with the HFD group, Figure 3B.  
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Figure 3. Effect of SAMe on HFD – induced changes in 
SH groups in rats. 
A ) SH groups sera: ***p < 0.05 HFD vs. control group; *p 
< 0.05 S-AMe vs. HFD group 
B ) SH groups adiposse tissue: **p < 0.05 HFD vs. control 
group; *p < 0.05 S-AMe vs. HFD group. 
 
3. Marker of inflammation.  
Changes in serum TNF-α levels. We found 
significantly elevated levels of TNF-α in the HFD group 
versus the control (p < 0.0005). In the S-AMe group, 
lower levels of pro-inflammatory cytokine were 
recorded as compared with the HFD group (p <0.0005), 
see Figure 4. 
 
 
Figure 4. Effect of SAMe on HFD – induced changes in 
TNF-α levels in rats 
***p < 0.05 HFD vs. control group; ***p < 0.05 S-AMe vs. 
HFD group 
 
Discussion 
Increased oxidative stress in visceral adipose tissue 
and the subsequent inflammatory processes are key 
pathogenic factors associated with the metabolic 
complications of obesity-insulin resistance, 
dyslipidemia, endothelial dysfunction, fatty liver 
degeneration and others. Expansion of fructose 
consumption is an important factor in the pathogenesis 
of obesity as it is associated with increased calorie intake 
and a positive energy balance (15-16). Our results 
indicate that the high fructose diet causes a significant 
increase in weight of the retroperitoneal adipose tissue 
that is closely related to the tested markers of oxidative 
stress and inflammation, whereas S-AMe intake results 
in reduction of adipose tissue, MDA, and serum TNF- α, 
and significantly elevates the levels of reduced 
glutathione in fatty tissue and serum.  
It has been shown that fructose is a highly lipogenic 
nutrient due to its conversion into fatty acids and 
activation of de novo lipogenesis in tissues, especially in 
enterocytes and the liver (17-18). In addition, its 
metabolism in the liver leads to hyperglycemia, 
regardless of the energy state of cells and serum glucose 
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levels (19). Taken together, these effects lead to obesity 
and hypertrophy of adipose tissue. The main 
mechanisms involved in generating ROS in fatty tissue 
in a fructose-rich diet are adipocyte hypoxia, increased 
uric acid formation, and activation of leukocytes and 
endothelial cells (20). Adipocyte hypoxia takes part in 
the attraction and retention of macrophages within it 
(important sources of ROS by activation of NADPH-
oxidase, myeloperoxidase and xanthine oxidase) (21) 
and in the inhibition of adipocyte differentiation, which 
is the cause of ectopic lipid deposition and subsequent 
metabolic injury (22). For example, Furukawa et al. 
2004 have established that inhibition of NADPH oxidase 
activity results in decreased generation of ROS and 
TNF-α in white adipose tissue and increased levels of 
adiponectin (9).  
In addition, HFD leads to increased uric acid 
formation (23) and superoxide radicals, and decreased 
expression of antioxidative enzymes (24). In a number 
of studies, hyperuricemia has been shown to cause 
systemic oxidative stress, suppress adiponectin 
secretion, reduce endothelial NO levels, and increase 
plasma triglycerides, which is a prerequisite for the 
development of insulin resistance, endothelial 
dysfunction, and hypertension (25). The ROS generated 
during these reactions induces the activation of lipid 
peroxidation, whose products are cytotoxic and deplete 
the cellular levels of reduced glutathione, thus 
potentiating the effects of oxidative stress (26). 
Reduced glutathione as a SH group donor is the 
main endogenous non-enzymatic antioxidant and 
modulator of redox status in tissue cells throughout the 
body (27). The liver is the major source of reduced 
glutathione and, at the same time, most frequently 
attacked in case of oxidative stress. Oxidative injuries of 
the liver disrupt its normal secretion and homeostasis in 
the entire organism (28). Decreased tissue levels are a 
common indicator of chronic oxidative stress (due to 
depletion) or impaired synthesis. Our data also confirm 
the presence of lipid peroxidation in adipose tissue and 
an imbalance in the anti-oxidative protection, as per the 
significantly higher levels of MDA and low levels of SH 
groups in the HFD versus control groups. 
Our results also showed a significant loss of serum 
SH groups in the fructose-fed group. In obesity and 
under conditions of insulin resistance, hypertrophic 
adipocytes are sources of free fatty acids that have a 
direct lipotoxic effect and maintain a pro-oxidant state 
throughout the body and especially in the liver, where 
the major amount of S-AMe is metabolized. S-AMe is 
the main endogenous donor of cysteine, which is 
required for glutathione synthesis. In another of our 
studies, we found that S-AMe administration increased 
the levels of SH groups in the liver under the conditions 
of oxidative stress, and it is probably through this 
mechanism that it protects against systemic oxidative 
stress (29). 
We assume that chronically increased ROS 
formation and suppression of anti-oxidative protection in 
hypertrophic fatty tissue induces oxidative damage and 
subsequent inflammation, which is the cause of elevated 
serum levels of TNF-α in the fructose-fed group, which 
were proportional to the increase in retroperitoneal 
adipose tissue and oxidative injury. The administration 
of S-AMe reduces these negative effects. In humans and 
rodents, macrophage infiltration into adipose tissue and 
serum levels of inflammatory mediators such as TNF-α, 
IL-6, and CRP have been shown to rise proportionally 
with the increase of Body Mass Index, body fat, and 
adipocyte hypertrophy, a reversible process upon loss of 
body weight (30). Both macrophages and adipocytes are 
sensitive to the effects of TNF-α, which, by activating 
the inflammatory IKK / NF- κB signaling pathway, also 
increases the expression of other mediators of 
inflammation such as acute - phase proteins, interleukin-
6, etc., resulting in a self-perpetuating cycle of increased 
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release of pro-inflammatory cytokines (31). S-AMe has 
been shown to inhibit in vitro the kinase activity of IKK-
b of the pro-inflammatory IKK-b / NF-kb signaling 
pathway in 3T3-L1 adipocytes and to suppress the TNF-
α – induced insulin resistance (32). These findings 
suggest that, in addition to its antioxidant activity, S-
AMe also exhibits an anti-inflammatory effect in vivo in 
a model of HFD obesity, which we report for the first 
time in this study. 
Our data also indicate that the exogenous application 
of S-AMe results in reduction of visceral adipose tissue. 
There is no evidence in the literature of the effect of S-
AMe on the accumulation of triglycerides in adipose 
tissue. In addition to being a glutathione precursor, S-
AMe is the active form of methionine that takes part in 
the methylation reactions of a large number of substrates 
- proteins, lipids and nucleic acids. Transmethylation of 
nucleic acids determines the epigenetic profile and 
transcriptional activity of key genes involved in cellular 
metabolism in all cell types (33). We presume that the 
adipose tissue reduction by means of S-AMe is possibly 
due to epigenetic changes in genes associated with the 
activity of lipid metabolism and energy balance. For 
example, hypermethylation of DNA (Deoxyribonucleic 
acid) promoter regions in FASN (a fatty acid synthesis 
regulating gene) reduces TG deposition in the liver (34). 
 
Conclusions 
In conclusion, our study shows the relationship 
between the level of hypertrophy in visceral adipose 
tissue and elevated markers of oxidative stress and 
inflammation in HFD. We presume that in obesity, a 
pro-oxidant state is maintained that is largely responsible 
for the development of subsequent metabolic 
complications. 
To our knowledge, our research is the first to show 
that S-AMe exhibits anti-oxidative and anti-
inflammatory activity in vivo by reducing fructose-
induced hypertrophy and oxidative and inflammatory 
damage in adipose tissue. These effects are likely to be 
essential for the normal functioning of adipocytes by 
reducing the risk of developing insulin resistance and 
hence the metabolic complications of obesity. 
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